CFH, VEGF and HTRA1 promoter genotype may influence the response to intravitreal ranibizumab therapy for neovascular age-related macular degeneration (Q43599183)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CFH, VEGF and HTRA1 promoter genotype may influence the response to intravitreal ranibizumab therapy for neovascular age-related macular degeneration |
scientific article |
Statements
1 reference
CFH, VEGF and HTRA1 promoter genotype may influence the response to intravitreal ranibizumab therapy for neovascular age-related macular degeneration (English)
1 reference
Martin McKibbin
1 reference
Manir Ali
1 reference
Shveta Bansal
1 reference
Paul D Baxter
1 reference
Kumi West
1 reference
Grange Williams
1 reference
Frances Cassidy
1 reference
Chris F Inglehearn
1 reference
10 May 2011
1 reference
1 reference
Identifiers
1 reference